Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.

× No keyword cloud information.

14 in total

1. Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent.

Authors: A Georges; A Hosslet; G Duvernay
Journal: Acta Cardiol Date: 1973 Impact factor: 1.718

2. Therapeutic effectiveness and plasma levels of a new antidysrhythmic drug: aprindine.

Authors: J P Van Durme; T Rosseel; M Bogaert
Journal: Acta Cardiol Date: 1974 Impact factor: 1.718

3. Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802).

Authors: J P Van Durme; M Rousseau; P Mbuyamba
Journal: Acta Cardiol Date: 1974 Impact factor: 1.718

4. The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent.

Authors: A F Fasola; R Carmichael
Journal: Acta Cardiol Date: 1974 Impact factor: 1.718

5. Aprindine (AC 1802), a new anti-arrhythmic drug.

Authors: H Kesteloot; W Van Mieghem; H De Geest
Journal: Acta Cardiol Date: 1973 Impact factor: 1.718

6. Quinidine for prophylaxis of arrhythmias in acute myocardial infarction.

Authors: S S Bloomfield; D W Romhilt; T C Chou; N O Fowler
Journal: N Engl J Med Date: 1971-10-28 Impact factor: 91.245

7. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

Authors: J Koch-Weser; S W Klein; L L Foo-Canto; J A Kastor; R W DeSanctis
Journal: N Engl J Med Date: 1969-12-04 Impact factor: 91.245

8. Editorial: Pharmacokinetics--master or servant?

Authors: C T Dollery
Journal: Eur J Clin Pharmacol Date: 1973-06 Impact factor: 2.953

9. Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors: J Koch-Weser; S W Klein
Journal: JAMA Date: 1971-03-01 Impact factor: 56.272

10. Lidocaine in acute myocardial infarction.

Authors: B Lown; C Vassaux
Journal: Am Heart J Date: 1968-10 Impact factor: 4.749

6 in total

1. Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction.

Authors: F Hagemeijer
Journal: Eur J Clin Pharmacol Date: 1975-10-10 Impact factor: 2.953

2. Dose-dependent pharmacokinetics of aprindine in healthy volunteers.

Authors: T Kobari; T Itoh; T Hirakawa; H Namekawa; T Suzuki; T Satoh; N Iida; F Ohtsu; H Hayakawa
Journal: Eur J Clin Pharmacol Date: 1984 Impact factor: 2.953

3. Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors: J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal: Drugs Date: 1978-04 Impact factor: 9.546

4. Comparison of the therapeutic effectiveness of aprindine, procainamide and quinidine in chronic ventricular dysrhythmias.

Authors: J P Van Durme; M G Bogaert; M T Rosseel
Journal: Br J Clin Pharmacol Date: 1974-12 Impact factor: 4.335

5. Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans.

Authors: O Teirlynck; F M Belpaire; F Andreasen
Journal: Eur J Clin Pharmacol Date: 1982 Impact factor: 2.953

Review 6. Reliability of antiarrhythmic drug plasma concentration monitoring.

Authors: F Follath; U Ganzinger; E Schuetz
Journal: Clin Pharmacokinet Date: 1983 Jan-Feb Impact factor: 6.447

6 in total